dr. schmid discusses the findings of impassion130 in tnbc
Published 5 years ago • 254 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:06
dr. schmid on the design and findings of the keynote-173 trial in tnbc
-
1:56
dr. schmid on benefit of pembrolizumab in patients with tnbc
-
4:47
tnbc: updated efficacy results from impassion130
-
2:33
applying impassion130 data to tnbc management
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
4:27
analysis of impassion130: pd-l1 testing in advanced tnbc
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
2:30
impassion130: immunotherapy for tnbc
-
27:45
treatment options for triple-negative breast cancer prof. peter schmid
-
4:27
the impassion130 study in metastatic tnbc
-
2:51
impassion130: design and preliminary efficacy
-
1:11
dr. yee discusses the categorization of triple-negative breast cancer
-
21:00
precision medicine in metastatic triple negative breast cancer
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
2:44
impassion130: addressing immune-related aes in tnbc management
-
4:56
results from the impassion 130 trial treating metastatic breast cancer
-
1:55
dr. jhaveri discusses the potential of immunotherapy in tnbc
-
7:19
impassion130 trial: os updates in metastatic tnbc